We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Apotex v. Pfizer
  • Gowling WLG
  • Canada
  • March 4 2009

The Court of Appeal dismissed the generic company's appeal and upheld the decision of the trial judge prohibiting Apotex entering the market until the expiry of the patent


Solvay v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • March 4 2009

The Court upheld the decision of the Minister refusing to list a patent on the Patent Register


G.D. Searle v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • March 4 2009

The Minister of Health removed a patent from the Patent Register on the basis that it was ineligible for listing


Novopharm v. Eli Lilly
  • Gowling WLG
  • Canada
  • March 4 2009

The Court dismissed a motion by the Canadian Generic Pharmaceutical Association (CGPA) requesting leave to intervene in Novopharm's appeal of a decision of the Federal Court


Pfizer v. Novopharm
  • Gowling WLG
  • Canada
  • June 24 2009

The Federal Court granted prohibition in respect of a patent claiming the use of sildenafil for the treatment of erectile dysfunction by oral administration


Celgene v. Canada
  • Gowling WLG
  • Canada
  • June 24 2009

Celgene is the current owner of several patents relating to thalidomide


Recent cases
  • Gowling WLG
  • Canada
  • August 21 2009

The Court granted an order of prohibition to Purdue in the face of Pharmascience’s allegations that the patent was invalid


Eli Lilly Canada Inc. v. Apotex; application to declare NOA null and void
  • Gowling WLG
  • Canada
  • November 2 2009

Apotex sent a NOA regarding the validity of a patent list on the Patent Register for an orally disintegrating tablet form of a drug


Sanofi-Aventis v. Novopharm; preliminary questions regarding costs assessment
  • Gowling WLG
  • Canada
  • November 2 2009

Sanofi had brought a proceeding against Novopharm and joined Schering as the respondentpatentee pursuant to the NOC Regulations


Sanofi-Aventis v. Canada; PMPRB decision
  • Gowling WLG
  • Canada
  • November 2 2009

Sanofi was seeking judicial review of an interlocutory decision of the Board, which was made during the course of dealings that had lasted a number of years